2013
DOI: 10.2217/iim.13.51
|View full text |Cite
|
Sign up to set email alerts
|

Central effects of cholinesterase inhibitors in Alzheimer’s disease: insights from advanced neuroimaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 87 publications
0
2
0
Order By: Relevance
“…Although the study of CS in the presence of a diagnosis of AD is usually driven by an interest in the clinical efficacy of the treatment rather than in the understanding of the mechanisms that lead to positive changes, it is important to estimate at least the extent to which CS contributes to any improvements when CS is only one component of a multimodal treatment. The use of cholinergic treatment for AD is based on specific hypotheses and is associated to an extensive literature that has described the specific changes at a neural level in patients with AD [12][13][14]. In contrast, the mechanisms of CS are not fully known.…”
Section: Part 1: Cognitive Stimulation In the Presence Of A Diagnosismentioning
confidence: 99%
See 1 more Smart Citation
“…Although the study of CS in the presence of a diagnosis of AD is usually driven by an interest in the clinical efficacy of the treatment rather than in the understanding of the mechanisms that lead to positive changes, it is important to estimate at least the extent to which CS contributes to any improvements when CS is only one component of a multimodal treatment. The use of cholinergic treatment for AD is based on specific hypotheses and is associated to an extensive literature that has described the specific changes at a neural level in patients with AD [12][13][14]. In contrast, the mechanisms of CS are not fully known.…”
Section: Part 1: Cognitive Stimulation In the Presence Of A Diagnosismentioning
confidence: 99%
“…that activates in the absence of explicit mental tasks. Based on this, measures of neuroimaging might become an important marker of treatment effects of CS, similarly to the way they can track down the impact of pharmacological treatment [12][13][14]. Our objective was, therefore, to summarise the main experimental findings in this research field, with particular focus on the timeline of AD and on its neural involvement.…”
mentioning
confidence: 99%